Clinical Trial Update: A Study of A-CAR028 Treatment in Subjects With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A-CAR028 is being studied in a Phase 1 trial for relapsed or refractory acute myeloid leukemia and the study is currently recruiting. The document provides an u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• A-CAR028

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Acute Myeloid Leukemia (AML), CAR-T Cell Therapy | Phase 1 | Status: RECRUITING